Wings Therapeutics

About:

Wings Therapeutics is a developer of genetic skin disease drug designed to improve the healing and integrity of the skin.

Website: https://www.wings-tx.com/

Description:

Wings Therapeutics is a developer of genetic skin disease drug designed to improve the healing and integrity of the skin. The company's drugs are focused on wound care, pain management and itch management, enabling patients treatment of mutation causing dystrophic epidermolysis bullosa.

Total Funding Amount:

$1.5M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Berkeley, California, United States

Founded Date:

2019-01-01

Founders:

Mark De Souza

Number of Employees:

1-10

Last Funding Date:

2019-06-06

IPO Status:

Private

Industries:

© 2025 bioDAO.ai